(Q35126259)

English

Comparative Physical and Pharmacologic Characteristics of Iodine-131 and Yttrium-90: Implications for Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma

scientific article published on April 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Comparative physical and pharmacologic characteristics of iodine-131 and yttrium-90: implications for radioimmunotherapy for patients with non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Comparative Physical and Pharmacologic Characteristics of Iodine-131 and Yttrium-90: Implications for Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma (English)

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

1 reference

based on heuristic

inferred from title

radioimmunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743990

1 January 2024

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

author name string

John P. Leonard

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743990

1 January 2024

Jeffry A. Siegel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743990

1 January 2024

Stanley J. Goldsmith

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743990

1 January 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743990

1 January 2024

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

full work available at URL

http://www.tandfonline.com/doi/pdf/10.1081/CNV-120016421

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

241-252

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Treatment of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

The potential for immunoconjugates in lymphoma therapy.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Treatment of lymphoma with radiolabeled antibody: elimination of tumor cells lacking target antigen

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

The radiobiological basis of total body irradiation

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenografts

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3).

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Radiation dose to patients and relatives incident to 131I therapy

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Radioimmunotherapy in the π-BCL1 B cell Lymphoma Model: Efficacy Depends on More Than Targeted Irradiation Alone

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiography

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Evaluation in a mouse model of a thyroid-blocking protocol for 131I antibody therapy (short communication)

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120016421

21 January 2018

Follicular lymphoma: prognostic factors for response and survival

1

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

5

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains

8

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma

14

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

17

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Cancer Research

24

50

2330

author name string

Sharkey R.M.

publication date

1990

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Cancer Research

33

49

4906

author name string

Press O.W.

publication date

1989

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Cancer Research

35

56

2123

author name string

Press O.W.

publication date

1996

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma

46

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas

50

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma

66

1 reference

10.1081/CNV-120016421

https://api.crossref.org/works/10.1081/CNV-120016421

1 January 2024

Identifiers

10.1081/CNV-120016421

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35126259&oldid=2042748816"